Magnus Axelson
- Molecular Biology top 10%
- Endocrinology, Diabetes and Metabolism top 1%
- Oncology top 5%
- Surgery top 10%
- Cancer Research top 5%
- Co-authors
- Jan SjövallOlle LarssonLeonard GirnitaAda GirnitaArmando BartolazziIngemar BjörkhemMonique SynguélakisEtienne‐Emile Baulieu
- Topics
- Growth Hormone and Insulin-like Growth Factors (14 papers)Drug Transport and Resistance Mechanisms (11 papers)Cholesterol and Lipid Metabolism (8 papers)
- Partner nations
- SwedenBelgiumUnited States
In The Last Decade
Magnus Axelson
65 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 108
- Molecular Biology 1.3k
- Endocrinology, Diabetes and Metabolism 845
- Oncology 629
- Surgery 459
- Cancer Research 369
Countries citing papers authored by Magnus Axelson
This map shows the geographic impact of Magnus Axelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magnus Axelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magnus Axelson more than expected).
Fields of papers citing papers by Magnus Axelson
This network shows the impact of papers produced by Magnus Axelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magnus Axelson. The network helps show where Magnus Axelson may publish in the future.
Co-authorship network of co-authors of Magnus Axelson
This figure shows the co-authorship network connecting the top 25 collaborators of Magnus Axelson. A scholar is included among the top collaborators of Magnus Axelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magnus Axelson. Magnus Axelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 17 | |
| 3 | 13 | |
| 4 | 19 | |
| 5 | 9 | |
| 6 | 18 | |
| 7 | 29 | |
| 8 | 27 | |
| 9 | 15 | |
| 10 | 54 | |
| 11 | 49 | |
| 12 | 20 | |
| 13 | 8 | |
| 14 | 126 | |
| 15 | 15 | |
| 16 | 33 | |
| 17 | 38 | |
| 18 | 101 | |
| 19 | 148 | |
| 20 | 18 |
About Magnus Axelson
Magnus Axelson is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Oncology, having authored 65 papers that have together received 2.6k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (14 papers), Drug Transport and Resistance Mechanisms (11 papers) and Cholesterol and Lipid Metabolism (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (845 citations), Behavioral Neuroscience (128 citations) and Cancer Research (369 citations). Magnus Axelson has collaborated with scholars based in Sweden, Belgium and United States. Frequent co-authors include Jan Sjövall, Olle Larsson, Leonard Girnita, Ada Girnita, Armando Bartolazzi, Ingemar Björkhem, Monique Synguélakis, Etienne‐Emile Baulieu, P Röbel and Reijo Vihko. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.